['Best proven care' not always the best control]

Area of Science:

• Medical Ethics
• Clinical Trial Design

Background:

• The Declaration of Helsinki (DoH) and Council for International Organizations of Medical Sciences (CIOMS) guidelines govern ethical clinical research.
• Debate exists regarding the adequacy of DoH versions (2000 vs. 2008/2013) in protecting control groups, particularly in placebo-controlled trials.

Purpose of the Study:

• To evaluate the protection offered to control groups in clinical trials by different versions of the Declaration of Helsinki.
• To compare the ethical standards of the DoH with the CIOMS guidelines regarding the treatment of control groups.

Main Methods:

• Critical analysis of ethical principles outlined in the 2000, 2008, and 2013 versions of the Declaration of Helsinki.
• Comparative assessment of the DoH and CIOMS guidelines concerning the rights of participants in control groups.

Main Results:

• The 2000 version of the DoH is internationally contested and does not inherently prevent non-innovative research.
• Both DoH versions inadequately protect control groups by not explicitly guaranteeing established interventions.
• CIOMS guidelines provide stronger protection, asserting control groups' right to established effective interventions, potentially exceeding the best proven intervention.

Conclusions:

• The Declaration of Helsinki requires revision to better safeguard control groups in clinical trials.
• The CIOMS guidelines present a more robust ethical framework for protecting control group participants, ensuring they receive necessary treatment.